Helen Roberts BAppSci MBA

Director of Business Development

Helen Roberts brings to Implicit over 18 years experience in the biotechnology and pharmaceutical sector in a variety of senior commercial roles. Her responsibilitieis have encompassed corporate and business development, leadership of sales, marketing and product development teams, strategic planning and public affairs. Most recently she served as Director, Clinical and Commercial Programs at Brisbane-based Agenix where she was responsible for strategic clinical and regulatory oversight, business development and commercialisation planning for their in vivo clot-imaging program. Prior to that she worked with a number of top tier firms including Merck, Bayer and American Cyanamid (now Wyeth) in roles of increasing scope and with responsibility for flagship brands, both in Australia and overseas. Helen graduated with a Bachelor of Applied Science in 1984 and earned her MBA from University of Technology, Sydney in 1995.